A prospective, multicenter, open-label trial of zoledronic acid in patients with hormone refractory prostate cancer.

Yonsei Med J · 2007 · PMC2628173 · PMID 18159593

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A subgroup analysis of patients with an analgesic score and pain score > 0 at the time of screening, showed a trend towards improvement for later infusions.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.